Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
Pope WB, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel PS, Lai A, Nghiemphu P, Rahmanuddin S, Goldin J.
Pope WB, et al.
Radiology. 2009 Jul;252(1):182-9. doi: 10.1148/radiol.2521081534.
Radiology. 2009.
PMID: 19561256
Clinical Trial.